Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection

Authors:
  • KAKosh Agarwal
    Kosh Agarwal
  • JNJunqi Niu
    Junqi Niu
  • YDYanhua Ding
    Yanhua Ding
  • EGEdward Gane
    Edward Gane
  • TNTuan Nguyen
    Tuan Nguyen
  • KAKatia Alves
    Katia Alves
  • MEMarc Evanchick
    Marc Evanchick
  • HZHany Zayed
    Hany Zayed
  • QHQi Huang
    Qi Huang
  • SKSteven Knox
    Steven Knox
  • LSLuisa Stamm
    Luisa Stamm
  • RCRichard Colonno
    Richard Colonno

Abstract
No abstract available